Jasper Therapeutics Inc (JSPR): Next-Year EPS Estimate 25.53%
As of 2026-03-31, Jasper Therapeutics Inc (JSPR) has a next-year EPS growth estimate of 25.53%.
On 2026-03-31, analyst consensus for JSPR's next-year EPS growth shifted from 48.39% to 25.53% — a negative change of 22.86 percentage points.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.53%
- EPS growth this year
- N/A
- EPS next quarter (est)
- N/A
- Last price
- $0.90
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-03-31 | 25.53% | N/A | N/A | $0.90 |
| 2026-03-30 | 48.39% | N/A | N/A | $1.05 |
| 2026-03-30 | 50.26% | N/A | N/A | $0.90 |
| 2026-03-30 | 50.26% | N/A | N/A | $0.90 |
| 2026-03-29 | 48.39% | N/A | N/A | $1.05 |
| 2026-03-29 | 48.39% | N/A | N/A | $1.05 |
| 2026-03-27 | 48.39% | N/A | N/A | $1.05 |
| 2026-03-26 | 48.39% | N/A | N/A | $1.11 |
| 2026-03-26 | 48.39% | N/A | N/A | $1.11 |
| 2026-03-26 | 48.39% | N/A | N/A | $1.11 |
| 2026-03-25 | 48.39% | N/A | N/A | $1.09 |
| 2026-03-25 | 45.26% | N/A | N/A | $1.09 |
| 2026-03-25 | 45.26% | N/A | N/A | $1.09 |
| 2026-03-24 | 48.39% | N/A | N/A | $1.15 |
| 2026-03-24 | 45.26% | N/A | N/A | $1.15 |
| 2026-03-24 | 45.26% | N/A | N/A | $1.15 |
| 2026-03-23 | 37.30% | N/A | N/A | $1.19 |
| 2026-03-20 | 42.67% | N/A | N/A | $1.23 |
| 2026-03-19 | 42.67% | N/A | N/A | $1.22 |
| 2026-03-18 | 42.67% | N/A | N/A | $1.22 |
| 2026-03-17 | 42.67% | N/A | N/A | $1.25 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Jasper Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-03-31, Jasper Therapeutics Inc (JSPR) has a next-year EPS growth estimate of 25.53%, based on analyst consensus.
When was the latest EPS estimate revision for JSPR?▾
The most recent revision occurred on 2026-03-31, when analysts adjusted the next-year EPS growth estimate from 48.39% to 25.53%.
What sector and industry does Jasper Therapeutics Inc belong to?▾
Jasper Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. JSPR appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Jasper Therapeutics Inc (JSPR) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports